Gennex Laboratories zooms on its associate company getting approval from TSPCB

27 Sep 2018 Evaluate

Gennex Laboratories is currently trading at Rs. 3.86, up by 0.27 points or 7.52% from its previous closing of Rs. 3.59 on the BSE.

The scrip opened at Rs. 3.70 and has touched a high and low of Rs. 3.95 and Rs. 3.70 respectively. So far 152622 shares were traded on the counter.

The BSE group 'X' stock of face value Rs. 1 has touched a 52 week high of Rs. 6.90 on 22-Dec-2017 and a 52 week low of Rs. 2.71 on 06-Jun-2018.

Last one week high and low of the scrip stood at Rs. 4.00 and Rs. 3.41 respectively. The current market cap of the company is Rs. 49.34 crore.

The promoters holding in the company stood at 22.06%, while the Non-Institutions held 77.94% stake in the company.

Gennex Laboratories’ Associate Company -- Deccan Remedies has received Consent order For Establishment - (CFE) issued by the Telangana State Pollution Control Board (TSPCB), Hyderabad to carryout manufacturing of Bulk Drugs and intermediates at its manufacturing facility situated at Zaheerabad (M), Sangareddy District, Telangana.

Gennex Laboratories is engaged in the manufacture and export of bulk drugs and intermediates. The product range of the company includes Guaiphenesin, Methocarbamol, Fluconazole and Phenazopyridine. 

Gennex Lab Share Price

17.15 -0.33 (-1.89%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.